• 1266 Citations
  • 21 h-Index
1982 …2019
If you made any changes in Pure these will be visible here soon.

Research Output 1982 2019

  • 1266 Citations
  • 21 h-Index
  • 89 Article
  • 13 Review article
  • 1 Comment/debate
Filter
Article
2019

Can we predict amyloid deposition by objective cognition and regional cerebral blood flow in patients with subjective cognitive decline?

Funaki, K., Nakajima, S., Noda, Y., Wake, T., Ito, D., Yamagata, B., Yoshizaki, T., Kameyama, M., Nakahara, T., Murakami, K., Jinzaki, M., Mimura, M. & Tabuchi, H., 2019 Jan 1, (Accepted/In press) In : Psychogeriatrics.

Research output: Contribution to journalArticle

Cerebrovascular Circulation
Regional Blood Flow
Amyloid
Cognition
Single-Photon Emission-Computed Tomography
1 Citation (Scopus)

Clinical effectiveness of repetitive transcranial magnetic stimulation treatment in children and adolescents with neurodevelopmental disorders: A systematic review

Masuda, F., Nakajima, S., Miyazaki, T., Tarumi, R., Ogyu, K., Wada, M., Tsugawa, S., Croarkin, P. E., Mimura, M. & Noda, Y., 2019 Jan 1, (Accepted/In press) In : Autism.

Research output: Contribution to journalArticle

Transcranial Magnetic Stimulation
Prefrontal Cortex
Therapeutics
Therapeutic Uses
Tic Disorders

Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study

Shah, P., Iwata, Y., Brown, E. E., Kim, J., Sanches, M., Takeuchi, H., Nakajima, S., Hahn, M., Remington, G., Gerretsen, P. & Graff-Guerrero, A., 2019 Jan 1, (Accepted/In press) In : European Archives of Psychiatry and Clinical Neuroscience.

Research output: Contribution to journalArticle

Clozapine
Schizophrenia
Therapeutics
Demography
Recurrence

Insight and medication adherence in schizophrenia: An analysis of the CATIE trial

Kim, J., Ozzoude, M., Nakajima, S., Shah, P., Caravaggio, F., Iwata, Y., De Luca, V., Graff-Guerrero, A. & Gerretsen, P., 2019 Jan 1, In : Neuropharmacology. 107634.

Research output: Contribution to journalArticle

Medication Adherence
Antipsychotic Agents
Schizophrenia
Clinical Trials
Hostility

Modulation of brain activity with transcranial direct current stimulation: Targeting regions implicated in impaired illness awareness in schizophrenia

Kim, J., Plitman, E., Nakajima, S., Alshehri, Y., Iwata, Y., Chung, J. K., Caravaggio, F., Menon, M., Blumberger, D. M., Pollock, B. G., Remington, G., De Luca, V., Graff-Guerrero, A. & Gerretsen, P., 2019 Sep 1, In : European Psychiatry. 61, p. 63-71 9 p.

Research output: Contribution to journalArticle

Cerebrovascular Circulation
Regional Blood Flow
Schizophrenia
Electrodes
Brain

Relationships between internet addiction and clinicodemographic and behavioral factors

ElSalhy, M., Miyazaki, T., Noda, Y., Nakajima, S., Nakayama, H., Mihara, S., Kitayuguchi, T., Higuchi, S., Muramatsu, T. & Mimura, M., 2019 Jan 1, In : Neuropsychiatric Disease and Treatment. 15, p. 739-752 14 p.

Research output: Contribution to journalArticle

Open Access
Internet
Social Networking
Psychology
Social Work
Students

Subiculum volumes associated with memory function in the oldest-old individuals aged 95 years and older

Eguchi, Y., Noda, Y., Nakajima, S., Tsugawa, S., Kida, H., Plitman, E., Graff-Guerrero, A., Chakravarty, M. M., Takayama, M., Arai, Y., Matsuda, H., Mimura, M. & Niimura, H., 2019 Jan 1, In : Geriatrics and Gerontology International.

Research output: Contribution to journalArticle

Hippocampus
examination
brain
regression
Regression Analysis
1 Citation (Scopus)
Dopamine Receptors
Cognition
Antipsychotic Agents
Schizophrenia
Clinical Trials
2018
1 Citation (Scopus)

Amotivation is associated with smaller ventral striatum volumes in older patients with schizophrenia

Caravaggio, F., Fervaha, G., Iwata, Y., Plitman, E., Chung, J. K., Nakajima, S., Mar, W., Gerretsen, P., Kim, J., Chakravarty, M. M., Mulsant, B., Pollock, B., Mamo, D., Remington, G. & Graff-Guerrero, A., 2018 Mar 1, In : International Journal of Geriatric Psychiatry. 33, 3, p. 523-530 8 p.

Research output: Contribution to journalArticle

Schizophrenia
Corpus Striatum
Antipsychotic Agents
Cognition
Dopamine D2 Receptors

Association between Neuropsychiatric Improvement and Neurocognitive Change in Alzheimer's Disease: Analysis of the CATIE-AD Study

Nagata, T., Shinagawa, S., Nakajima, S., Mimura, M. & Shigeta, M., 2018 Jan 1, In : Journal of Alzheimer's disease : JAD. 66, 1, p. 139-148 10 p.

Research output: Contribution to journalArticle

Antipsychotic Agents
Alzheimer Disease
Clinical Trials
Psychiatry
Therapeutics

Correlates of neurocognitive functions in individuals at ultra-high risk for psychosis - A 6-month follow-up study

Sanada, K., de Azúa, S. R., Nakajima, S., Alberich, S., Ugarte, A., Zugasti, J., Vega, P., Martínez-Cengotitabengoa, M. & González-Pinto, A., 2018 Oct 1, In : Psychiatry Research. 268, p. 1-7 7 p.

Research output: Contribution to journalArticle

Brain-Derived Neurotrophic Factor
Psychotic Disorders
Verbal Learning
Control Groups
Executive Function
4 Citations (Scopus)

Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study

Wada, M., Noda, Y., Shinagawa, S., Chung, J. K., Sawada, K., Ogyu, K., Tarumi, R., Tsugawa, S., Miyazaki, T., Yamagata, B., Graff-Guerrero, A., Mimura, M. & Nakajima, S., 2018 Jan 1, In : Journal of Alzheimer's Disease. 63, 2, p. 861-869 9 p.

Research output: Contribution to journalArticle

Neuroimaging
Healthy Volunteers
Alzheimer Disease
Cross-Sectional Studies
Biomarkers
6 Citations (Scopus)

Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies

Moriguchi, S., Takamiya, A., Noda, Y., Horita, N., Wada, M., Tsugawa, S., Plitman, E., Sano, Y., Tarumi, R., ElSalhy, M., Katayama, N., Ogyu, K., Miyazaki, T., Kishimoto, T., Graff-Guerrero, A., Meyer, J. H., Blumberger, D. M., Daskalakis, Z. J., Mimura, M. & Nakajima, S., 2018 Jan 1, (Accepted/In press) In : Molecular Psychiatry.

Research output: Contribution to journalArticle

Major Depressive Disorder
Meta-Analysis
Depression
Frontal Lobe
Glutamic Acid
6 Citations (Scopus)

Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study

Iwata, Y., Nakajima, S., Plitman, E., Caravaggio, F., Kim, J., Shah, P., Mar, W., Chavez, S., De Luca, V., Mimura, M., Remington, G., Gerretsen, P. & Graff-Guerrero, A., 2018 Jan 1, (Accepted/In press) In : Biological Psychiatry.

Research output: Contribution to journalArticle

Schizophrenia
Antipsychotic Agents
Glutamic Acid
Glutamine
Therapeutics
4 Citations (Scopus)

Neuroimaging correlates of narcolepsy with cataplexy: A systematic review

Wada, M., Mimura, M., Noda, Y., Takasu, S., Plitman, E., Honda, M., Natsubori, A., Ogyu, K., Tarumi, R., Graff-Guerrero, A. & Nakajima, S., 2018 Jan 1, (Accepted/In press) In : Neuroscience Research.

Research output: Contribution to journalArticle

Cataplexy
Narcolepsy
Neuroimaging
Gyrus Cinguli
Multimodal Imaging

Pharmacotherapy for Alzheimer’s disease: a perspective on treatment strategies in Japan

Nagata, T., Nakajima, S., Shinagawa, S., Noda, Y. & Mimura, M., 2018 Jan 1, (Accepted/In press) In : Expert Opinion on Pharmacotherapy.

Research output: Contribution to journalArticle

Japan
Alzheimer Disease
Drug Therapy
Therapeutics
Tokyo
Cognition
Demography
Health
Activities of Daily Living
3 Citations (Scopus)

Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability study

Plitman, E., Chavez, S., Nakajima, S., Iwata, Y., Chung, J. K., Caravaggio, F., Kim, J., Alshehri, Y., Chakravarty, M. M., De Luca, V., Remington, G., Gerretsen, P. & Graff-Guerrero, A., 2018 Mar 30, In : Psychiatry Research - Neuroimaging. 273, p. 16-24 9 p.

Research output: Contribution to journalArticle

Corpus Striatum
Antipsychotic Agents
Schizophrenia
Glutamic Acid
Inositol
2017
6 Citations (Scopus)

Anosognosia g pIS an independent py g predictor of conversion y From mild cognitive impairment to Alzheimer’s disease and is associated with reduced brain metabolism

Alzheimer’s Disease Neuroimaging Initiative, 2017 Nov 1, In : Journal of Clinical Psychiatry. 78, 9, p. e1187-e1196

Research output: Contribution to journalArticle

Agnosia
Alzheimer Disease
Brain
Dementia
Positron-Emission Tomography
1 Citation (Scopus)

Baseline predictors of antipsychotic treatment continuation and response at week 8 in patients with Alzheimer's disease with psychosis or aggressive symptoms: An analysis of the CATIE-AD study

Nagata, T., Nakajima, S., Shinagawa, S., Plitman, E., Nakayama, K., Graff-Guerrero, A. & Mimura, M., 2017, In : Journal of Alzheimer's Disease. 60, 1, p. 263-272 10 p.

Research output: Contribution to journalArticle

Psychotic Disorders
Antipsychotic Agents
Alzheimer Disease
Clinical Trials
olanzapine
4 Citations (Scopus)

Cognition and Dopamine D2 Receptor Availability in the Striatum in Older Patients with Schizophrenia

Rajji, T. K., Mulsant, B. H., Nakajima, S., Caravaggio, F., Suzuki, T., Uchida, H., Gerretsen, P., Mar, W., Pollock, B. G., Mamo, D. C. & Graff-Guerrero, A., 2017 Jan 1, In : American Journal of Geriatric Psychiatry. 25, 1, p. 1-10 10 p.

Research output: Contribution to journalArticle

Dopamine D2 Receptors
Cognition
Schizophrenia
olanzapine
Antipsychotic Agents
3 Citations (Scopus)

Corticotropin-releasing hormone and dopamine release in healthy individuals

Payer, D., Williams, B., Mansouri, E., Stevanovski, S., Nakajima, S., Le Foll, B., Kish, S., Houle, S., Mizrahi, R., George, S. R., George, T. P. & Boileau, I., 2017 Feb 1, In : Psychoneuroendocrinology. 76, p. 192-196 5 p.

Research output: Contribution to journalArticle

Corticotropin-Releasing Hormone
Dopamine
Positron-Emission Tomography
Hormone Antagonists
Injections
5 Citations (Scopus)

Exploring the relationship between social attachment and dopamine D2/3 receptor availability in the brains of healthy humans using [11C]-(+)-PHNO

Caravaggio, F., Chung, J. K., Gerretsen, P., Fervaha, G., Nakajima, S., Plitman, E., Iwata, Y., Wilson, A. & Graff-Guerrero, A., 2017 Mar 4, In : Social Neuroscience. 12, 2, p. 163-173 11 p.

Research output: Contribution to journalArticle

Dopamine D2 Receptors
tomography
Corpus Striatum
brain
Positron-Emission Tomography
3 Citations (Scopus)

Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease Pathology

Chung, J. K., Plitman, E., Nakajima, S., Caravaggio, F., Iwata, Y., Gerretsen, P., Kim, J., Takeuchi, H., Shinagawa, S., Patel, R., Chakravarty, M. M. & Graff-Guerrero, A., 2017, In : Journal of Alzheimer's Disease. 58, 3, p. 747-762 16 p.

Research output: Contribution to journalArticle

Pathology
Amyloid
Apolipoprotein E4
Cognitive Dysfunction
Genotype

Impaired illness awareness and leftward visuospatial inattention in schizophrenia are attributable to a common neural deficit – Posterior parietal hemispheric imbalance

Kim, J., Plitman, E., Nakajima, S., Chung, J. K., Alshehri, Y., Iwata, Y., Caravaggio, F., Pollock, B. G., Pothier, D., Graff-Guerrero, A. & Gerretsen, P., 2017 Mar 1, In : Medical Hypotheses. 100, p. 19-22 4 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Intranasal oxytocin does not modulate jumping to conclusions in schizophrenia: Potential interactions with caudate volume and baseline social functioning

Caravaggio, F., Gerretsen, P., Mar, W., Chung, J. K., Plitman, E., Nakajima, S., Kim, J., Iwata, Y., Patel, R., Chakravarty, M. M., Remington, G., Graff-Guerrero, A. & Menon, M., 2017 Jul 1, In : Psychoneuroendocrinology. 81, p. 80-87 8 p.

Research output: Contribution to journalArticle

Oxytocin
Schizophrenia
Placebos
Corpus Striatum
Cross-Over Studies
1 Citation (Scopus)

Investigating the effects of norepinephrine α1 receptor blockade on dopamine levels: A pilot PET study with [11C]-(+)-PHNO in controls

Le Foll, B., Thiruchselvam, T., Lu, S. X., Mohammed, S., Mansouri, E., Lagzdins, D., Nakajima, S., Wilson, A. A., Graff-Guerrero, A., Di Ciano, P. & Boileau, I., 2017 Jul 1, In : Synapse. 71, 7, e21968.

Research output: Contribution to journalArticle

Prazosin
Positron-Emission Tomography
Adrenergic Receptors
Dopamine
Norepinephrine
2 Citations (Scopus)

Self-rated cognitive functions following chemotherapy in patients with breast cancer: A 6-month prospective study

Kitahata, R., Nakajima, S., Uchida, H., Hayashida, T., Takahashi, M., Nio, S., Hirano, J., Nagaoka, M., Suzuki, T., Jinno, H., Kitagawa, Y. & Mimura, M., 2017 Oct 3, In : Neuropsychiatric Disease and Treatment. 13, p. 2489-2496 8 p.

Research output: Contribution to journalArticle

Cognition
Prospective Studies
Breast Neoplasms
Drug Therapy
Checklist
2 Citations (Scopus)

The Effects of Cortical Hypometabolism and Hippocampal Atrophy on Clinical Trajectories in Mild Cognitive Impairment with Suspected Non-Alzheimer's Pathology: A Brief Report

Chung, J. K., Plitman, E., Nakajima, S., Caravaggio, F., Shinagawa, S., Iwata, Y., Gerretsen, P., Kim, J., Takeuchi, H., Patel, R., Chakravarty, M. M., Strafella, A. & Graff-Guerrero, A., 2017, In : Journal of Alzheimer's Disease. 60, 2, p. 341-347 7 p.

Research output: Contribution to journalArticle

Atrophy
Pathology
Dementia
Cognition
Amyloid
144 Citations (Scopus)

Treatment-ResistantSchizophrenia: TreatmentResponse and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

Howes, O. D., McCutcheon, R., Agid, O., De Bartolomeis, A., Van Beveren, N. J. M., Birnbaum, M. L., Bloomfield, M. A. P., Bressan, R. A., Buchanan, R. W., Carpenter, W. T., Castle, D. J., Citrome, L., Daskalakis, Z. J., Davidson, M., Drake, R. J., Dursun, S., Ebdrup, B. H., Elkis, H., Falkai, P., Fleischacker, W. W. & 31 others, Gadelha, A., Gaughran, F., Glenthøj, B. Y., Graff-Guerrero, A., Hallak, J. E. C., Honer, W. G., Kennedy, J., Kinon, B. J., Lawrie, S. M., Lee, J., Leweke, F. M., MacCabe, J. H., McNabb, C. B., Meltzer, H., Möller, H. J., Nakajima, S., Pantelis, C., Marques, T. R., Remington, G., Rossell, S. L., Russell, B. R., Siu, C. O., Suzuki, T., Sommer, I. E., Taylor, D., Thomas, N., Üçok, A., Umbricht, D., Walters, J. T. R., Kane, J. & Correll, C. U., 2017 Mar 1, In : American Journal of Psychiatry. 174, 3, p. 216-229 14 p.

Research output: Contribution to journalArticle

Terminology
Psychotic Disorders
Consensus
Guidelines
Therapeutics
2016
3 Citations (Scopus)
Benzodiazepines
Amyloid
Positron-Emission Tomography
Cognition
Aminobutyrates
9 Citations (Scopus)

Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study

Nagata, T., Shinagawa, S., Nakajima, S., Plitman, E., Mihashi, Y., Hayashi, S., Mimura, M. & Nakayama, K., 2016 Feb 2, In : Journal of Alzheimer's Disease. 50, 3, p. 839-845 7 p.

Research output: Contribution to journalArticle

Apathy
Antipsychotic Agents
Alzheimer Disease
Clinical Trials
Eating
15 Citations (Scopus)

Depressive symptoms and small hippocampal volume accelerate the progression to dementia from mild cognitive impairment

Chung, J. K., Plitman, E., Nakajima, S., Mallar Chakravarty, M., Caravaggio, F., Takeuchi, H., Gerretsen, P., Iwata, Y., Patel, R., Mulsant, B. H. & Graff-Guerrero, A., 2016, In : Journal of Alzheimer's Disease. 49, 3, p. 743-754 12 p.

Research output: Contribution to journalArticle

Dementia
Depression
Apolipoprotein E4
1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride
Cognitive Dysfunction
16 Citations (Scopus)

Dopamine D2/3 Receptor Occupancy Following Dose Reduction Is Predictable with Minimal Plasma Antipsychotic Concentrations: An Open-Label Clinical Trial

Nakajima, S., Uchida, H., Bies, R. R., Caravaggio, F., Suzuki, T., Plitman, E., Mar, W., Gerretsen, P., Pollock, B. G., Mulsant, B. H., Mamo, D. C. & Graff-Guerrero, A., 2016 Jan 1, In : Schizophrenia Bulletin. 42, 1, p. 212-219 8 p.

Research output: Contribution to journalArticle

olanzapine
Dopamine D2 Receptors
Risperidone
Antipsychotic Agents
Clinical Trials
6 Citations (Scopus)
Major Depressive Disorder
Depression
Sleep Initiation and Maintenance Disorders
Randomized Controlled Trials
Logistic Models
12 Citations (Scopus)

Exploring personality traits related to dopamine D2/3 receptor availability in striatal subregions of humans

Caravaggio, F., Fervaha, G., Chung, J. K., Gerretsen, P., Nakajima, S., Plitman, E., Iwata, Y., Wilson, A. & Graff-Guerrero, A., 2016 Apr 1, In : European Neuropsychopharmacology. 26, 4, p. 644-652 9 p.

Research output: Contribution to journalArticle

Corpus Striatum
Dopamine D2 Receptors
Personality
Socialization
Globus Pallidus
8 Citations (Scopus)

Lack of association between dopaminergic antagonism and negative symptoms in schizophrenia: a positron emission tomography dopamine D2/3 receptor occupancy study

Fervaha, G., Caravaggio, F., Mamo, D. C., Mulsant, B. H., Pollock, B. G., Nakajima, S., Gerretsen, P., Rajji, T. K., Mar, W., Iwata, Y., Plitman, E., Chung, J. K., Remington, G. & Graff-Guerrero, A., 2016 Oct 1, In : Psychopharmacology. 233, 21-22, p. 3803-3813 11 p.

Research output: Contribution to journalArticle

Dopamine D2 Receptors
Positron-Emission Tomography
Antipsychotic Agents
Schizophrenia
Raclopride
8 Citations (Scopus)

Occupancy of Dopamine D3 and D2 Receptors by Buspirone: A [11C]-(+)-PHNO PET Study in Humans

Le Foll, B., Payer, D., Di Ciano, P., Guranda, M., Nakajima, S., Tong, J., Mansouri, E., Wilson, A. A., Houle, S., Meyer, J. H., Graff-Guerrero, A. & Boileau, I., 2016 Jan 1, In : Neuropsychopharmacology. 41, 2, p. 529-537 9 p.

Research output: Contribution to journalArticle

Dopamine D3 Receptors
Buspirone
Dopamine D2 Receptors
Positron-Emission Tomography
Pharmaceutical Preparations
8 Citations (Scopus)
Antipsychotic Agents
Alzheimer Disease
Apathy
Demography
Clinical Trials
1 Citation (Scopus)

Relapse of ileus in patients with psychiatric disorders: A 2-year chart review

Kitahata, R., Nakajima, S., Suzuki, T., Plitman, E., Mimura, M. & Uchida, H., 2016 Jan 1, In : General Hospital Psychiatry. 38, p. 31-36 6 p.

Research output: Contribution to journalArticle

Ileus
varespladib methyl
Psychiatry
Recurrence
Odds Ratio
12 Citations (Scopus)

The effect of striatal dopamine depletion on striatal and cortical glutamate: A mini-review

Caravaggio, F., Nakajima, S., Plitman, E., Gerretsen, P., Chung, J. K., Iwata, Y. & Graff-Guerrero, A., 2016 Feb 4, In : Progress in Neuro-Psychopharmacology and Biological Psychiatry. 65, p. 49-53 5 p.

Research output: Contribution to journalArticle

Corpus Striatum
Glutamic Acid
Dopamine
Basal Ganglia
Neuroimaging
5 Citations (Scopus)

Threshold of dopamine D2/3 receptor occupancy for hyperprolactinemia in older patients with schizophrenia

Iwata, Y., Nakajima, S., Caravaggio, F., Suzuki, T., Uchida, H., Plitman, E., Chung, J. K., Mar, W., Gerretsen, P., Pollock, B. G., Mulsant, B. H., Rajji, T. K., Mamo, D. C. & Graff-Guerrero, A., 2016 Dec 1, In : Journal of Clinical Psychiatry. 77, 12, p. e1557-e1563

Research output: Contribution to journalArticle

Hyperprolactinemia
Dopamine D2 Receptors
Prolactin
Schizophrenia
olanzapine
2015
11 Citations (Scopus)

Comparative efficacy between clozapine and other atypical antipsychotics on depressive symptoms in patients with schizophrenia: Analysis of the CATIE phase 2E data

Nakajima, S., Takeuchi, H., Fervaha, G., Plitman, E., Chung, J. K., Caravaggio, F., Iwata, Y., Mihashi, Y., Gerretsen, P., Remington, G., Mulsant, B. & Graff-Guerrero, A., 2015 Feb 1, In : Schizophrenia Research. 161, 2-3, p. 429-433 5 p.

Research output: Contribution to journalArticle

Clozapine
Antipsychotic Agents
Schizophrenia
olanzapine
Depression
17 Citations (Scopus)

Cortical Amyloid β Deposition and Current Depressive Symptoms in Alzheimer Disease and Mild Cognitive Impairment

Chung, J. K., Plitman, E., Nakajima, S., Chakravarty, M. M., Caravaggio, F., Gerretsen, P., Iwata, Y., Graff-Guerrero, A. & Alzheimer's Disease Neuroimaging Initiative, D. N. I., 2015 Jan 1, In : Journal of Geriatric Psychiatry and Neurology. 29, 3, p. 149-159 11 p.

Research output: Contribution to journalArticle

Amyloid
Alzheimer Disease
Depression
Parietal Lobe
Gyrus Cinguli
11 Citations (Scopus)

Dopamine D<inf>2/3</inf> receptor availability in the striatum of antipsychotic-free older patients with schizophrenia-A [<sup>11</sup>C]-raclopride PET study

Nakajima, S., Caravaggio, F., Mamo, D. C., Mulsant, B. H., Chung, J. K., Plitman, E., Iwata, Y., Gerretsen, P., Uchida, H., Suzuki, T., Mar, W., Wilson, A. A., Houle, S. & Graff-Guerrero, A., 2015 May 1, In : Schizophrenia Research. 164, 1-3, p. 263-267 5 p.

Research output: Contribution to journalArticle

Raclopride
Dopamine D2 Receptors
Antipsychotic Agents
Schizophrenia
Globus Pallidus
45 Citations (Scopus)

Effects of glutamate positive modulators on cognitive deficits in schizophrenia: A systematic review and meta-Analysis of double-blind randomized controlled trials

Iwata, Y., Nakajima, S., Suzuki, T., Keefe, R. S. E., Plitman, E., Chung, J. K., Caravaggio, F., Mimura, M., Graff-Guerrero, A. & Uchida, H., 2015 Oct 29, In : Molecular Psychiatry. 20, 10, p. 1151-1160 10 p.

Research output: Contribution to journalArticle

Meta-Analysis
Glutamic Acid
Schizophrenia
Randomized Controlled Trials
Cognition
33 Citations (Scopus)

Evaluation of antipsychotic dose reduction in late-life schizophrenia: A prospective dopamine D<inf>2/3</inf> receptor occupancy study

Graff-Guerrero, A., Rajji, T. K., Mulsant, B. H., Nakajima, S., Caravaggio, F., Suzuki, T., Uchida, H., Gerretsen, P., Mar, W., Pollock, B. G. & Mamo, D. C., 2015 Sep 1, In : JAMA Psychiatry. 72, 9, p. 927-934 8 p.

Research output: Contribution to journalArticle

Dopamine D2 Receptors
Antipsychotic Agents
Schizophrenia
Corpus Striatum
Brief Psychiatric Rating Scale
3 Citations (Scopus)

Fear conditioning induced by interpersonal conflicts in healthy individuals

Tada, M., Uchida, H., Maeda, T., Konishi, M., Umeda, S., Terasawa, Y., Nakajima, S., Mimura, M., Miyazaki, T. & Takahashi, T., 2015 May 15, In : PLoS One. 10, 5, 0125729.

Research output: Contribution to journalArticle

conditioned behavior
fearfulness
Fear
Skin
behavior disorders
15 Citations (Scopus)

Imaging the D3 dopamine receptor across behavioral and drug addictions: Positron emission tomography studies with [11C]-(+)-PHNO

Boileau, I., Nakajima, S. & Payer, D., 2015 Jan 1, In : European Neuropsychopharmacology. 25, 9, p. 1410-1420 11 p.

Research output: Contribution to journalArticle

Dopamine D3 Receptors
Positron-Emission Tomography
Substance-Related Disorders
Dopamine D2 Receptors
Up-Regulation
12 Citations (Scopus)

Lack of age-dependent decrease in dopamine D 3 receptor availability: A [11C]-(+)-PHNO and [11C]-raclopride positron emission tomography study

Nakajima, S., Caravaggio, F., Boileau, I., Chung, J. K., Plitman, E., Gerretsen, P., Wilson, A. A., Houle, S., Mamo, D. C. & Graff-Guerrero, A., 2015 Jan 1, In : Journal of Cerebral Blood Flow and Metabolism. 35, 11, p. 1812-1818 7 p.

Research output: Contribution to journalArticle

Raclopride
Positron-Emission Tomography
Dopamine
Putamen
Corpus Striatum